Skip to content
10-K

Annual Report

CAPRICOR THERAPEUTICS, INC. CAPR

0001104659-26-029580

← back to feed
Filed
Mar 17, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 16, 2026 57.51M sh
Shares Diluted FY 2025 · Dec 31, 2025 46.48M sh
Shares Diluted FY 2025 · Dec 31, 2024 35.22M sh
Capex FY 2025 · Dec 31, 2025 $2.9M
Capex FY 2025 · Dec 31, 2024 $1.17M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$69.81M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$40M
Cash And Equivalents FY 2025 · Dec 31, 2025 $287.85M
Cash And Equivalents FY 2025 · Dec 31, 2024 $11.29M
Stockholders Equity FY 2025 · Dec 31, 2025 $305.79M
Stockholders Equity FY 2025 · Dec 31, 2024 $145.46M
Stockholders Equity FY 2025 · Dec 31, 2023 $22.6M
Current Liabilities FY 2025 · Dec 31, 2025 $35.84M
Current Liabilities FY 2025 · Dec 31, 2024 $21.03M
Total Liabilities FY 2025 · Dec 31, 2025 $50.16M
Total Liabilities FY 2025 · Dec 31, 2024 $25.02M
Current Assets FY 2025 · Dec 31, 2025 $322.94M
Current Assets FY 2025 · Dec 31, 2024 $163.39M
Total Assets FY 2025 · Dec 31, 2025 $355.95M
Total Assets FY 2025 · Dec 31, 2024 $170.48M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.26
Eps Diluted FY 2025 · Dec 31, 2024 −$1.15
Eps Basic FY 2025 · Dec 31, 2025 −$2.26
Eps Basic FY 2025 · Dec 31, 2024 −$1.15
Sga Expense FY 2025 · Dec 31, 2025 $23.69M
Sga Expense restated FY 2025 · Dec 31, 2024 $14.87M
Rd Expense FY 2025 · Dec 31, 2025 $84.45M
Rd Expense FY 2025 · Dec 31, 2024 $49.97M
Net Income FY 2025 · Dec 31, 2025 −$105.04M
Net Income FY 2025 · Dec 31, 2024 −$40.47M
Operating Income FY 2025 · Dec 31, 2025 −$108.14M
Operating Income restated FY 2025 · Dec 31, 2024 −$42.56M
Revenue FY 2025 · Dec 31, 2025 $0
Revenue FY 2025 · Dec 31, 2024 $22.27M